Denavir Indication Understood By 99% of Respondents in Actual Use Study
This article was originally published in The Tan Sheet
Executive Summary
The proposed OTC use of SmithKline Beecham's Denavir for recurrent cold sores in immunocompetent adults was correctly understood by more than 99% of respondents in a large actual use study conducted by the company.